Standard BioTools (NASDAQ:LAB – Get Free Report) and Stevanato Group (NYSE:STVN – Get Free Report) are both healthcare companies, but which is the superior business? Get Standard BioTools alerts:Valuation and EarningsThis table compares Standard BioTools and Stevanato Group”s top-line revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Standard BioTools $85.33 million 3.63 -$74.90 million $0.22 3.59 Stevanato Group $1.34 billion 4.66 $158.21 million €0.56 36.87Stevanato Group has higher revenue and earnings than Standard BioTools. Given Standard BioTools’ higher possible upside, research analysts plainly believe Standard BioTools is more favorable than Stevanato Group. Net Margins Return on Equity Return on Assets Standard BioTools 100.36% -7.57% -6.14% Stevanato Group 10.99% 10.43% 6.16%SummaryStevanato Group beats Standard BioTools on 10 of the 15 factors compared between the two stocks.